The Difference Between Delamanid and Bedaquiline
Delamanid and bedaquiline are both new generation anti-tuberculosis drugs used to treat multidrug-resistant tuberculosis (MDR-TB). They are both effective anti-tuberculosis drugs, but their mechanisms of action, efficacy, and side effects are slightly different. Delamanid is an antibiotic used to treat multidrug-resistant tuberculosis, while bedaquiline is indicated for combination therapy in adults(≥18 years) patients with multidrug-resistant tuberculosis (MDR-TB).

Delamanid is a drug that inhibits cell wall synthesis. It blocks the formation of the tuberculosis cell wall by inhibiting the activity of acetyl-CoA carboxylase in bacterial wall synthesis. It is usually used in combination with other anti-tuberculosis drugs and is used to treat MDR-TB, especially in patients who are ineffective in other drug treatments. It is used in oral form. Common side effects of delamanid include nausea, vomiting, diarrhea, joint pain, and rash. Serious side effects may include liver damage and irregular heartbeat. Bedaquiline is an ATP synthase inhibitor that inhibits the growth and replication of bacteria by interfering with the energy metabolism within tuberculosis cells. It is also used in combination with other anti-tuberculosis drugs to treat MDR-TB. It is taken in oral form. Common side effects include nausea, vomiting, dizziness and joint pain. Serious side effects may include irregular heartbeat and liver damage.
The original drug Delamani has been launched in China and is included in the scope of Class B medical insurance. Reimbursement is limited to patients with multi-drug-resistant tuberculosis. Specifications The price of each box of 50mg*60 tablets may be around RMB 6,000. The price of the Russian version of the original drug Dramani, 50mg*48 tablets, sold overseas may be around RMB 1,000-2,000 per box (the price may fluctuate due to the exchange rate). There is currently no generic version of Dramani available on the market. For more drug information and specific prices, please consult Yaode’s medical consultant.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)